C. elegans for anti-infective discovery

Marios Arvanitis, Justin Glavis-Bloom, Eleftherios Mylonakis

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

Widespread use of antimicrobial agents has led to the emergence of multidrug resistant pathogens, which are becoming increasingly common in clinical practice. This underscores the need to discover novel anti-infective compounds. The soil-living nematode Caenorhabditis elegans has proved to be an excellent model host in the search for such compounds. Indeed, this alternative host is successfully being used to identify traditional microbicidal agents, including antihelminthic compounds, as well as novel agents that attenuate microbial virulence or enhance the host's immune response. Thanks to numerous advantageous features, including its amenability to high-throughput automated screens that allow for the detection of bioactive products among thousands of tested substances, the C. elegans model is now in the spotlight of scientific attention.

Original languageEnglish (US)
Pages (from-to)769-774
Number of pages6
JournalCurrent Opinion in Pharmacology
Volume13
Issue number5
DOIs
StatePublished - Oct 2013

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'C. elegans for anti-infective discovery'. Together they form a unique fingerprint.

Cite this